dr. gralow gives an analysis of the apt trial
Published 10 years ago • 176 plays • Length 2:33Download video MP4
Download video MP3
Similar videos
-
2:48
dr. gralow on a comparison of toxicities and patient-stated preference in the swog s0307 trial
-
16:11
dr. julie r. gralow discusses findings from the rxponder study released at sabcs 2020
-
6:11
understanding her2climb clinical trial
-
1:27
dr. julie gralow on the importance of genetic testing for breast cancer
-
58:27
linking cancer metabolism to neurodegeneration
-
5:17
hope after glioblastoma diagnosis
-
28:02
2022 west oncology conference | breast cancers | early-stage
-
4:09
glioblastoma clinical trial: the frontier study
-
1:13
dr. julie gralow discusses t-dm1-induced thrombocytopenia
-
1:57
dr. gralow on adjuvant bisphosphonates for breast cancer
-
5:07
julie gralow, md, summarizes the rxponder trial from the 2020 san antonio breast cancer symposium
-
4:52
3-year dfs in randomized trials of chemotherapy and her2-targeted therapy
-
2:23
an overview of the neomonarch trial in hr /her2- breast cancer
-
1:05
julie gralow, md, speaks to the significance of the monaleesa-3 study
-
1:00
an analysis of the results of the beth study
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
10:05
dr. julie r. gralow on her2-positive early breast cancer
-
2:35
julie gralow, md, elaborates on the issue of resistance to endocrine therapies
-
2:03
genomic analysis of calgb 40601 for her2-positive breast cancer
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
2:11
dr. gogineni on implications of the apt trial in her2 breast cancer
-
1:56
apt: adjuvant paclitaxel and trastuzumab for node-negative, her2 breast cancer